Erratum: 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways (Molecular Medicine Reports (2016) 15 (153-159) DOI: 10.3892/mmr.2016.5991);5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways

Molecular Medicine Reports

Volumn 15, Issue 1, 2017, Pages 153-159

  Yu, Guo Qiang ^a   Dou, Zhong Ling ^a   Jia, Zhao Hui ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Bladder cancer; Caspases; Cell cycle; Mitochondrial

Indexed keywords

2 PYRONE DERIVATIVE; 5 BROMO 3 (3 HYDROXYPROP 1 YNYL) 2H PYRAN 2 ONE; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CASPASE; CYCLIN E; DNA; ENDONUCLEASE G; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; 5-BROMO-3-(3-HYDROXYPROP-1-YNYL)-2H-PYRAN-2-ONE; PYRONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER CELL LINE; BLADDER CARCINOMA; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BLADDER; CELL CYCLE; CELL CYCLE CHECKPOINT; DRUG EFFECTS; METABOLISM; MITOCHONDRION; PATHOLOGY; TUMOR CELL LINE; URINARY BLADDER NEOPLASMS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PYRONES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 85006364695     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.6076     Document Type: Erratum

References (29)

1. Kaufman DS, Shipley WU and Feldman AS: Bladder cancer. Lancet 374: 239-249, 2009.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Kwak C, Ku JH, Park JY, Lee E, Lee SE and Lee C: Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. J Urol 171: 149-152, 2004.
4. Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, BanderN, et al: Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 64: 2448-2458, 1989.
5. Orren DK, Petersen LN and Bohr VA: Persistent DNA damage inhibits S-phase and G2 progression and results in apoptosis. Mol Biol Cell 8: 1129-1142, 1997.
6. Fujimoto K, Hosotani R, Doi R, Wada M, Lee JU, Koshiba T, Miyamoto Y, Tsuji S, Nakajima S and Imamura M: Induction of cell-cycle arrest and apoptosis by a novel retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer cells. Int J Cancer 81: 637-644, 1999.
7. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J and Tercé F: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60: 1426-1433, 2000.
8. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA and Yuan J: Caspase-l2 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98-103, 2000.
9. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y and Alnemri ES: A conserved XIAP-interaction motif in caspase-9 and Smac/DiABLO regulates caspase activity and apoptosis. Nature 409: 112-116, 2001.
10. Degterev A, Boyce M and Yuan J: A decade of caspases. Oncogene 22: 8543-8567, 2003.
11. Ziegler DS and Kung AL: Therapeutic targeting of apoptosis pathways in cancer. Curr Opin Oncol 20: 97-103, 2008.
12. Jensen PR and Fenical W: Strategies for the discovery of secondary metabolites from marine bacteria: Ecological perspectives. Annu Rev Microbiol 48: 559-584, 1994.
13. Faulkner DJ: Marine natural products. Nat Prod Rep 18: 1-49, 2001.
14. McGlacken GP and Fairlamb IJ: 2-Pyrone natural products and mimetics: Isolation, characterisation and biological activity. Nat Prod Rep 22: 369-385, 2005.
15. Dickinson JM: Microbial pyran-2-ones and dihydropyran-2-ones. Nat Prod Rep 10: 71-98, 1993.
16. Thaisrivongs S, Romero DL, Tommasi RA, Janakiraman MN, Strohbach JW, Turner SR, Biles C, Morge RR, Johnson PD, Aristoff PA, et al: Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors. J Med Chem 39: 4630-4642, 1996.
17. Poppe SM, Slade DE, Chong KT, Hinshaw RR, Pagano PJ, Markowitz M, Ho DD, Mo H, Gorman RR III, Dueweke TJ, et al: Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. Antimicrob Agents Chemother 41: 1058-1063, 1997.
18. Turner SR, Strohbach JW, Tommasi RA, Aristoff PA, Johnson PD, Skulnick HI, Dolak LA, Seest EP, Tomich PK, Bohanon MJ, et al: Tipranavir (PNU-140690): A potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem 41: 3467-3476, 1998.
19. Trachootham D, Lu W, Ogasawara MA, Nilsa RD and Huang P: Redox regulation of cell survival. Antioxid Redox Signal 10: 1343-1374, 2008.
20. Hartwell LH and Weinert TA: Checkpoints: Controls that ensure the order of cell cycle events. Science 246: 629-634, 1989.
21. Adams JM and Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 281: 1322-1326, 1998.
22. Antonsson B and Martinou JC: The Bcl-2 protein family. Exp Cell Res 256: 50-57, 2000.
23. Salvesen GS and Dixit VM: Caspases: Intracellular signaling by proteolysis. Cell 91: 443-446, 1997.
24. Rauh R, Kahl S, Boechzelt H, Bauer R, Kaina B and Efferth T: Molecular biology of cantharidin in cancer cells. Chin Med 2: 8, 2007.
25. Ozben T: Oxidative stress and apoptosis: Impact on cancer therapy. J Pharm Sci 96: 2181-2196, 2007.
26. Xiao L, Eto M and Kazanietz MG: ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 upregulation and JNK. J Biol Chem 284: 29365-29375, 2009.
27. Lin KL, Su JC, Chien CM, Tseng CH, Chen YL, Chang LS and Lin SR: Naphtho [1,2-b]furan-4,5-dione induces apoptosis and S-phase arrest of MDA-MB-231 cells through JNK and ERK signaling activation. Toxicol In Vitro 24: 61-70, 2010.
28. Choi YJ, Kim SY, Oh JM and Juhnn YS: Stimulatory heterotrimeric G protein augments gamma ray-induced apoptosis by up-regulation of Bak expression via CREB and AP-1 in HL299 human lung cancer cells. Exp Mol Med 41: 592-600, 2009.
29. An L, Dong GQ, Gao Q, Zhang Y, Hu LW, Li JH and Liu Y: Effects of UVA on TNF-αlpha, IL-1beta, and IL-10 expression levels in human keratinocytes and intervention studies with an antioxidant and a JNK inhibitor. Photodermatol Photoimmunol Photomed 26: 28-35, 2010.